TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Orifarm Healthcare AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
56,020
|
58,012
|
63,462 |
| Financial expenses |
31
|
122
|
215 |
| Earnings before taxes |
1,321
|
1,165
|
1,002 |
| Total assets |
12,276
|
17,234
|
24,035 |
| Current assets |
12,092
|
16,970
|
23,756 |
| Current liabilities |
9,871
|
14,777
|
22,371 |
| Equity capital |
2,405
|
2,456
|
1,665 |
| - share capital |
42
|
44
|
47 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
19.6%
|
14.3%
|
6.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
2.4%
|
2.0%
|
1.6% |
| Return on assets (ROA) |
11.0%
|
7.5%
|
5.1% |
| Current ratio |
122.5%
|
114.8%
|
106.2% |
| Return on equity (ROE) |
54.9%
|
47.4%
|
60.2% |
| Change turnover |
973
|
-1,418
|
14,864 |
| Change turnover % |
2%
|
-2%
|
31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.